Dna X (SONM) Total Current Liabilities (2018 - 2026)

Dna X has reported Total Current Liabilities for 9 years, with the latest figure at $4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 87.54% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (down 87.54% YoY), and the FY2025 full-year result was $50.6 million, up 15.74% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $4.3 million, down from $50.6 million in the prior quarter.
• The five-year high for Total Current Liabilities was $50.6 million in Q4 2025, with the low at $4.3 million in Q1 2026.
• Historically, Total Current Liabilities has averaged $30.8 million across 5 years, with a median of $32.1 million in 2022.
• Annual changes were most pronounced in 2025 — Total Current Liabilities surged 65.33% — and 2026, when it slumped 87.54%.
• Dna X's Total Current Liabilities stood at $32.1 million in 2022, then grew by 0.27% to $32.1 million in 2023, then jumped by 36.06% to $43.7 million in 2024, then rose by 15.74% to $50.6 million in 2025, then plunged by 91.46% to $4.3 million in 2026.
• The last three Total Current Liabilities figures came in at $4.3 million (Q1 2026), $50.6 million (Q4 2025), and $38.9 million (Q3 2025), per Business Quant data.